Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies. 1995

E Rønne, and G Høyer-Hansen, and N Brünner, and H Pedersen, and F Rank, and C K Osborne, and G M Clark, and K Danø, and J Grøndahl-Hansen
Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.

Urokinase plasminogen activator (uPA) is a proteolytic enzyme involved in degradation of the extracellular matrix during cancer invasion. The levels of uPA and its inhibitor PAI-1 in tumor extracts have previously been demonstrated to be of prognostic value in breast cancer as well as other types of cancer. We have previously characterized a specific cell surface receptor for uPA (uPAR) which strongly enhances the catalytic activity of uPA and is expressed during mammary cancer invasion. In order to quantitate uPAR in breast cancer tissue, we have now developed a sensitive enzyme-linked immunosorbent assay (ELISA), with polyclonal catching antibodies and three monoclonal detecting antibodies. The detection limit of the assay is approximately 0.16 fmol of uPAR in a volume of 100 microliters (1.6 pM). There is a linear relationship between signal and uPAR concentration up to at least 6.6 fmol per 100 microliters (66 pM). Both free uPAR and uPAR in complex with uPA is detected. The recovery of an internal uPAR standard in breast cancer tissue extracts is above 87%. The intra-assay and inter-assay variation coefficients are 7% and 13%. In order to find a suitable buffer for extraction of various components of the uPA-system from breast cancer tissue, we tested buffers which previously have been used for optimal extraction of estrogen receptor (A), uPA (B), and uPAR (C). Buffer A and B extracted approximately 30% and 50%, respectively, of the amount of uPAR extracted with buffer C.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002021 Buffers A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. Buffer
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

E Rønne, and G Høyer-Hansen, and N Brünner, and H Pedersen, and F Rank, and C K Osborne, and G M Clark, and K Danø, and J Grøndahl-Hansen
December 1993, Breast cancer research and treatment,
E Rønne, and G Høyer-Hansen, and N Brünner, and H Pedersen, and F Rank, and C K Osborne, and G M Clark, and K Danø, and J Grøndahl-Hansen
January 1986, Journal of immunoassay,
E Rønne, and G Høyer-Hansen, and N Brünner, and H Pedersen, and F Rank, and C K Osborne, and G M Clark, and K Danø, and J Grøndahl-Hansen
December 1988, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
E Rønne, and G Høyer-Hansen, and N Brünner, and H Pedersen, and F Rank, and C K Osborne, and G M Clark, and K Danø, and J Grøndahl-Hansen
April 1987, Clinica chimica acta; international journal of clinical chemistry,
E Rønne, and G Høyer-Hansen, and N Brünner, and H Pedersen, and F Rank, and C K Osborne, and G M Clark, and K Danø, and J Grøndahl-Hansen
December 1983, Planta,
E Rønne, and G Høyer-Hansen, and N Brünner, and H Pedersen, and F Rank, and C K Osborne, and G M Clark, and K Danø, and J Grøndahl-Hansen
November 1977, Journal of clinical microbiology,
E Rønne, and G Høyer-Hansen, and N Brünner, and H Pedersen, and F Rank, and C K Osborne, and G M Clark, and K Danø, and J Grøndahl-Hansen
September 2003, Clinical and diagnostic laboratory immunology,
E Rønne, and G Høyer-Hansen, and N Brünner, and H Pedersen, and F Rank, and C K Osborne, and G M Clark, and K Danø, and J Grøndahl-Hansen
November 2003, Clinical and diagnostic laboratory immunology,
E Rønne, and G Høyer-Hansen, and N Brünner, and H Pedersen, and F Rank, and C K Osborne, and G M Clark, and K Danø, and J Grøndahl-Hansen
January 1983, Diagnostic immunology,
E Rønne, and G Høyer-Hansen, and N Brünner, and H Pedersen, and F Rank, and C K Osborne, and G M Clark, and K Danø, and J Grøndahl-Hansen
July 1989, Journal of clinical microbiology,
Copied contents to your clipboard!